Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons

American Journal of Cardiology

Volumn 86, Issue 5, 2000, Pages 585-586

  Aronow, Wilbert S ^a,b   Ahn, Chul ^c   Gutstein, Hal ^a  

^a HEBREW HOSPITAL HOME   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 0034284154     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01025-0     Document Type: Article

References (11)

1. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
2. Bostom A.G., Rosenberg I.H., Silbershatz H., Jacques P.F., Selhub J., D'Agostino R.B., Wilson P.W.F., Wolf P.A. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons the Framingham study . Ann Intern Med. 131:1999;352-355.
3. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
4. Petri M., Roubenoff R., Dallal G.E., Nadeau M.R., Selhub J., Rosenberg I.H. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet. 348:1996;1120-1124.
5. Alfthan G., Pekkanen J., Jauhiainen M., Pitkaniemi J., Karvonen M., Tuomilehto J., Salonen J.T., Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19.
6. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., Stampfer M.J. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke. 25:1994;1924-1930.
7. Aronow W.S., Ahn C. Association between plasma homocysteine and coronary artery disease in older persons. Am J Cardiol. 80:1997;1216-1218.
8. Aronow W.S., Ahn C., Gutstein H. Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women. Am J Cardiol. 77:1996;1381-1383.
9. The Sixth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 157:1997;2413-2444.
10. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1997;1183-1197.
11. Master A.M., Lasser R.P., Beckman G. Tables of average weight and height of Americans aged 65 to 94 years relationship of weight and height to survival . JAMA. 172:1960;658-662.